Ilico Genetics
Updated: February 08, 2026
Founder Fernando Alarcon
Country: Chile | Funding: $1.1M (+)
Founded: 2022
Website: https://www.ilicogenetics.com
Ilico Genetics is a subsidiary of the Pontificia Universidad Católica de Chile, that developed GastroMDx - liquid biopsy test for the early detection of gastric cancer. According to the company, it is the first methylated DNA-based molecular test specifically designed for the early detection of gastric cancer - detecting the disease years before the current "gold standard" esophagogastroduodenoscopy (EGD) can detect it. GastroMDx uses molecular biomarkers based on genetic and epigenetic signatures - subtle changes in DNA or RNA expression patterns - that can indicate the early presence of malignancy.
Founded: 2022
Website: https://www.ilicogenetics.com
Ilico Genetics is a subsidiary of the Pontificia Universidad Católica de Chile, that developed GastroMDx - liquid biopsy test for the early detection of gastric cancer. According to the company, it is the first methylated DNA-based molecular test specifically designed for the early detection of gastric cancer - detecting the disease years before the current "gold standard" esophagogastroduodenoscopy (EGD) can detect it. GastroMDx uses molecular biomarkers based on genetic and epigenetic signatures - subtle changes in DNA or RNA expression patterns - that can indicate the early presence of malignancy.
